These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19111800)

  • 1. Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA).
    Loeb S; Gashti SN; Catalona WJ
    Urol Oncol; 2009; 27(1):64-6. PubMed ID: 19111800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate specific antigen decrease and prostate cancer diagnosis: antibiotic versus placebo prospective randomized clinical trial.
    Stopiglia RM; Ferreira U; Silva MM; Matheus WE; Denardi F; Reis LO
    J Urol; 2010 Mar; 183(3):940-4. PubMed ID: 20089269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum PSA and percent free PSA value changes after antibiotic treatment. A diagnostic method in prostate cancer suspects with asymptomatic prostatitis.
    Kobayashi M; Nukui A; Morita T
    Urol Int; 2008; 80(2):186-92. PubMed ID: 18362491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can antibiotic treatment exclude inflammation in the differential diagnosis of elevated PSA?].
    Liu J; Hu WL
    Zhonghua Nan Ke Xue; 2012 Aug; 18(8):747-50. PubMed ID: 22934524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis.
    Hochreiter WW
    Andrologia; 2008 Apr; 40(2):130-3. PubMed ID: 18336465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Asymptomatic prostatitis: a frequent cause of raising PSA].
    Terrone C; Poggio M; Bollito E; Cracco CM; Scarpa RM
    Recenti Prog Med; 2005; 96(7-8):365-9. PubMed ID: 16209120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is chronic inflammatory change in the prostate the major cause of rising serum prostate-specific antigen in patients with clinical suspicion of prostate cancer?
    Chang SG; Kim CS; Jeon SH; Kim YW; Choi BY
    Int J Urol; 2006 Feb; 13(2):122-6. PubMed ID: 16563135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum prostate specific antigen (PSA) related to asymptomatic prostatic inflammation.
    Hoekx L; Jeuris W; Van Marck E; Wyndaele JJ
    Acta Urol Belg; 1998 Oct; 66(3):1-2. PubMed ID: 9864868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml.
    Kaygisiz O; Uğurlu O; Koşan M; Inal G; Oztürk B; Cetinkaya M
    Prostate Cancer Prostatic Dis; 2006; 9(3):235-8. PubMed ID: 16718277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
    Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
    Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
    Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A
    Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice patterns of urologists in managing Korean men aged 40 years or younger with high serum prostate-specific antigen levels.
    Yoo DS; Woo SH; Cho S; Kang SH; Kim SJ; Park SY; Lee SH; Jeon SH; Park J
    Urology; 2014 Jun; 83(6):1339-43. PubMed ID: 24726151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSA doubling time as a predictive factor on repeat biopsy for detection of prostate cancer.
    Shimbo M; Tomioka S; Sasaki M; Shima T; Suzuki N; Murakami S; Nakatsu H; Shimazaki J
    Jpn J Clin Oncol; 2009 Nov; 39(11):727-31. PubMed ID: 19674994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications and timing for prostate biopsy, diagnosis of early stage prostate cancer and its definitive treatment: a clinical conundrum in the PSA era.
    Punnen S; Nam RK
    Surg Oncol; 2009 Sep; 18(3):192-9. PubMed ID: 19282170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient information - what is a PSA test?
    Brett T
    Aust Fam Physician; 2011 Jul; 40(7):501. PubMed ID: 21743855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
    Fitzpatrick JM; Banu E; Oudard S
    BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there any clinical parameter able to predict prostate cancer after initial diagnosis of atypical small acinar proliferation?
    Mearini L; Costantini E; Bellezza G; Cavaliere A; Zucchi A; Bini V; Porena M
    Urol Int; 2008; 81(1):29-35. PubMed ID: 18645268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
    Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
    Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer.
    Schröder FH; Roobol MJ
    Curr Opin Urol; 2009 May; 19(3):227-31. PubMed ID: 19357513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatitis and prostate cancer: implications for prostate cancer screening.
    Kawakami J; Siemens DR; Nickel JC
    Urology; 2004 Dec; 64(6):1075-80. PubMed ID: 15596172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.